Published on 11 Oct 2022 on Insider Monkey via Yahoo Finance

10 Best Immunotherapy Stocks To Buy Now

In this article, we discuss 10 best immunotherapy stocks to buy now. If you want to read about some more immunotherapy stocks, go directly to 5 Best Immunotherapy Stocks To Buy Now.

The global immunotherapy market is rapidly evolving as technological, regulatory, and economic trends combine to alter the growth and risk dynamics within the industry. According to a report by market research firm BCC Research, the global market for immunotherapy drugs could be worth more than $204 billion in value by 2025, up from $139 billion in 2020, representing an annual growth rate of close to 8%. The estimates are based on analysis of new products, regulatory scenarios, and the challenges and opportunities affecting market growth. 

Within the immunotherapy universe, cancer immunotherapies are the largest market. According to data compiled by the American Cancer Society, of all drug approvals between 2010 and 2018, 27% were cancer therapies, compared with 4% in the 1980s. Despite this explosive growth, cancer remains the leading cause of death globally, accounting for nearly 10 million deaths in 2020. To put this figure into context, the coronavirus pandemic killed about 3 million people in the same year.